ABEO
What one share of Abeona Therapeutics holds
Pharmaceutical Preparations
Abeona Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.41 |
|---|---|
| Profit | −$1.06 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | −$1.31 |
| Cash and investments | $0.98 |
| Debt | $0.26 |
| Book value | $2.24 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.65 | −$16.00 | $0.38 | −$9.90 | — | $61.54 |
| 2017 | $0.50 | −$16.40 | $0.52 | −$14.12 | — | $90.69 |
| 2018 | $1.58 | −$29.81 | $4.86 | −$25.43 | — | $69.90 |
| 2019 | — | −$37.87 | $3.13 | −$34.32 | — | $53.34 |
| 2020 | $2.70 | −$22.73 | $0.36 | −$9.81 | — | $26.67 |
| 2021 | $0.76 | −$21.57 | $1.05 | −$17.73 | — | $7.20 |
| 2022 | $0.18 | −$5.53 | $0.02 | −$5.55 | — | — |
| 2023 | $0.16 | −$2.53 | $0.02 | −$1.75 | — | $0.56 |
| 2024 | — | −$1.55 | $0.06 | −$1.42 | — | $0.96 |
| 2025 | $0.09 | $1.01 | $0.12 | −$1.27 | — | $2.89 |